(Q34498286)

2 August 2017

title

A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results (English)

1 reference

2 August 2017

A J Demetris

1 reference

2 August 2017

T E Starzl

1 reference

2 August 2017

S M Pham

1 reference

2 August 2017

R L Kormos

1 reference

2 August 2017

B G Hattler

1 reference

2 August 2017

A Kawai

1 reference

2 August 2017

A C Tsamandas

1 reference

2 August 2017

S Murali

1 reference

2 August 2017

F J Fricker

1 reference

2 August 2017

H C Chang

1 reference

2 August 2017

A B Jain

1 reference

2 August 2017

R L Hardesty

1 reference

2 August 2017

B P Griffith

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

The Journal of Thoracic and Cardiovascular Surgery

2 August 2017

published in

1 reference

2 August 2017

volume

111

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

764-772

1 reference

One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

The problem of attributing deaths of nonadherers: the VA coronary bypass experience.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Infections after liver transplantation. An analysis of 101 consecutive cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

FK 506 for liver, kidney, and pancreas transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

A whole blood FK 506 assay for the IMx analyzer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Early trials with FK 506 as primary treatment in liver transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Clinical trial of FK 506 immunosuppression in adult cardiac transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022508

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

27 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2896%2970336-7

Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2896%2970336-7

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2896%2970336-7

Side effects of cyclosporin A treatment in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2896%2970336-7

Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2896%2970336-7

Improved immunosuppression for heart transplantation

7 January 2021

1 reference

12 December 2020

Preparation and in vitro assay of effective and ineffective antilymphocyte sera

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group

1 reference

12 December 2020

Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat

1 reference

12 December 2020

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes

1 reference

12 December 2020

10.1016/S0022-5223(96)70336-7

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference